We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.85B
AUM Growth
+$519M
Cap. Flow
+$404M
Cap. Flow %
21.87%
Top 10 Hldgs %
27.4%
Holding
120
New
9
Increased
56
Reduced
4
Closed
10

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$54.3M
2
CYBR
CyberArk
CYBR
+$36.5M
3
ABBV icon
AbbVie
ABBV
+$26.6M
4
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
+$18.5M
5
IMPV
Imperva, Inc.
IMPV
+$18.2M

Top Sells

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$20.5M
2
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
+$11.8M
3
CXP
COLUMBIA PROPERTY TRUST, INC.
CXP
+$10.6M
4
VMW
VMware, Inc
VMW
+$8.02M
5
OII icon
Oceaneering
OII
+$7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.49%
2 Technology 26.09%
3 Consumer Discretionary 12.82%
4 Industrials 9.62%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDTX
101
DELISTED
Cidara Therapeutics
CDTX
$1.72M 0.09%
+6,131
New +$1.89M
TNDM icon
102
Tandem Diabetes Care
TNDM
$1.3B
$1.68M 0.09%
15,530
+2,560
+20% +$318K
SAAS
103
DELISTED
inContact, Inc.
SAAS
$1.48M 0.08%
150,000
-43,300
-22% -$443K
INFI
104
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.23M 0.07%
112,600
– –
FEIC
105
DELISTED
FEI COMPANY
FEIC
$1.23M 0.07%
14,800
– –
MDSO
106
DELISTED
Medidata Solutions, Inc.
MDSO
$1.03M 0.06%
18,900
– –
XOMA
107
DELISTED
Xoma
XOMA
$591K 0.03%
7,610
-1,250
-14% -$90K
RPTP
108
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$253K 0.01%
16,000
-14,000
-47% -$170K
VSTM icon
109
Verastem
VSTM
$536M
$82K ﹤0.01%
908
-834
-48% -$88.2K
CDXS icon
110
Codexis
CDXS
$159M
$39K ﹤0.01%
10,000
– –
ADVM
111
DELISTED
Adverum Biotechnologies
ADVM
– –
-3,740
Closed -$1.51M
FC icon
112
Franklin Covey
FC
$243M
– –
-224,964
Closed -$4.33M
LRMR icon
113
Larimar Therapeutics
LRMR
$397M
– –
-50
Closed -$24K
OII icon
114
Oceaneering
OII
$4.74B
– –
-129,700
Closed -$7M
PCRX icon
115
Pacira BioSciences
PCRX
$1.06B
– –
-13,300
Closed -$1.18M
TFX icon
116
Teleflex
TFX
$5.86B
– –
-5,800
Closed -$701K
LUMO
117
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-23,967
Closed -$11.8M
VMW
118
DELISTED
VMware, Inc
VMW
– –
-97,800
Closed -$8.02M
CXP
119
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
– –
-393,800
Closed -$10.6M
SNDK
120
DELISTED
SANDISK CORP
SNDK
– –
-321,800
Closed -$20.5M
1 2 3 4
5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Eventide Asset Management held 120 positions worth $1.85B, up 39% from $1.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $404M of net new capital in Q2 2015, opening 9 new positions and adding to 56 existing holdings. Its largest new stake was CyberArk: 570,000 shares worth $35.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was inContact, Inc., an estimated $443K trimmed.

  • Eventide Asset Management's largest Q2 2015 buy was CyberArk: 570,000 shares worth $35.8M.
  • Eventide Asset Management added most to Celgene Corp in Q2 2015, an estimated $54.3M increase.
  • Eventide Asset Management's biggest Q2 2015 reduction was inContact, Inc., cutting an estimated $443K.
  • Eventide Asset Management fully exited SANDISK CORP in Q2 2015, selling an estimated $20.5M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $1.85B portfolio in Q2 2015.
  • Eventide Asset Management opened 9 new positions and closed 10 in Q2 2015.
  • Eventide Asset Management's portfolio value rose 39% quarter-over-quarter to $1.85B.

Based on Eventide Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.